scorecardresearch
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
Nippon India Pharma Fund - Direct Plan - Bonus Plan
Nippon India Pharma Fund - Direct Plan - Bonus Plan

Nippon India Pharma Fund - Direct Plan - Bonus Plan

  • Very High Risk
  • Equity
  • Sector - Healthcare
  • Share
  • Whatsapp
  • Twitter
  • Facebook
NAV as on Mar 13, 2025
i
Price per unit of the scheme.
₹ 515.2431 -0.09% 1 Day Change
-2.24%
Minimum Investment ₹5000
Expense Ratio 1.03%

FUND RATING

A holistic measure of the rank of a fund relative to its peers. Top funds receive a score of 5.

RISK-O-METER

Level of risk associated with a mutual fund to help investors make informed investment decisions
 

FUND PERFORMANCE

(As On --)
Compare fund’s performance against category average across different time periods
-- Out of -- funds in the category
Category Avg Return
--
Fund Return
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
For calculating Category Return & Scheme Ranking, only Growth & Direct schemes are considered.

RETURN CALCULATOR

Check the return on your investment in the fund
Nippon India Pharma Fund - Direct Plan - Bonus Plan
Investment Type
MONTHLY SIP ONE -TIME
Monthly Investment
Time Period (yrs)
Annual Return in %
  • Invested Amount
    0
  • Return
    0
  • Current Value
    ₹0

FUND MANAGER

Sailesh Raj Bhan
i
Lead Fund Manager.
Apr 1, 2005- Present
  • Fund Manager Rank 11 Out of 22
    i
    Rank measured on the basis of consistent alpha the fund manager delivered in the same category over a period of three years (factors only Direct plan, Growth option)
  • Schemes managed 3
  • Total AUM ₹ 81,421.70 Cr
  • Highest Return In 1 Yr 12.49 %
Other Funds
  • table
  • card
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
-2.24%
-4.14%
Very High Risk
₹8,160.74Cr
₹278.52
-2.34%
-3.91%
Very High Risk
₹37,593.67Cr
₹88.07
-2.55%
-3.10%
Very High Risk
₹35,667.30Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
-8.63%
-9.83%
Very High Risk
₹8,160.74Cr
₹278.52
-14.83%
-15.89%
Very High Risk
₹37,593.67Cr
₹88.07
-11.74%
-11.82%
Very High Risk
₹35,667.30Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
-11.73%
-11.92%
Very High Risk
₹8,160.74Cr
₹278.52
-16.02%
-16.52%
Very High Risk
₹37,593.67Cr
₹88.07
-12.01%
-13.53%
Very High Risk
₹35,667.30Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹515.24
12.49%
15.33%
Very High Risk
₹8,160.74Cr
₹278.52
9.21%
6.72%
Very High Risk
₹37,593.67Cr
₹88.07
5.57%
3.28%
Very High Risk
₹35,667.30Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
18.45%
17.30%
Very High Risk
₹8,160.74Cr
₹278.52
22.74%
16.72%
Very High Risk
₹37,593.67Cr
₹88.07
19.26%
12.46%
Very High Risk
₹35,667.30Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
26.94%
25.22%
Very High Risk
₹8,160.74Cr
₹278.52
27.05%
23.39%
Very High Risk
₹37,593.67Cr
₹88.07
23.58%
18.64%
Very High Risk
₹35,667.30Cr
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -2.24%
Category Return -4.14%
Nippon India Multi Cap Fund - Direct Plan - Growth Nippon India Multi Cap Fund - Direct Plan - Growth
Very High Risk
  • NAV ₹278.52
  • Fund Size ₹37,593.67Cr
Fund Return -2.34%
Category Return -3.91%
Nippon India Large Cap Fund - Direct Plan - Growth Plan Nippon India Large Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹88.07
  • Fund Size ₹35,667.30Cr
Fund Return -2.55%
Category Return -3.10%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -8.63%
Category Return -9.83%
Nippon India Multi Cap Fund - Direct Plan - Growth Nippon India Multi Cap Fund - Direct Plan - Growth
Very High Risk
  • NAV ₹278.52
  • Fund Size ₹37,593.67Cr
Fund Return -14.83%
Category Return -15.89%
Nippon India Large Cap Fund - Direct Plan - Growth Plan Nippon India Large Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹88.07
  • Fund Size ₹35,667.30Cr
Fund Return -11.74%
Category Return -11.82%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -11.73%
Category Return -11.92%
Nippon India Multi Cap Fund - Direct Plan - Growth Nippon India Multi Cap Fund - Direct Plan - Growth
Very High Risk
  • NAV ₹278.52
  • Fund Size ₹37,593.67Cr
Fund Return -16.02%
Category Return -16.52%
Nippon India Large Cap Fund - Direct Plan - Growth Plan Nippon India Large Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹88.07
  • Fund Size ₹35,667.30Cr
Fund Return -12.01%
Category Return -13.53%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 12.49%
Category Return 15.33%
Nippon India Multi Cap Fund - Direct Plan - Growth Nippon India Multi Cap Fund - Direct Plan - Growth
Very High Risk
  • NAV ₹278.52
  • Fund Size ₹37,593.67Cr
Fund Return 9.21%
Category Return 6.72%
Nippon India Large Cap Fund - Direct Plan - Growth Plan Nippon India Large Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹88.07
  • Fund Size ₹35,667.30Cr
Fund Return 5.57%
Category Return 3.28%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 18.45%
Category Return 17.30%
Nippon India Multi Cap Fund - Direct Plan - Growth Nippon India Multi Cap Fund - Direct Plan - Growth
Very High Risk
  • NAV ₹278.52
  • Fund Size ₹37,593.67Cr
Fund Return 22.74%
Category Return 16.72%
Nippon India Large Cap Fund - Direct Plan - Growth Plan Nippon India Large Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹88.07
  • Fund Size ₹35,667.30Cr
Fund Return 19.26%
Category Return 12.46%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 26.94%
Category Return 25.22%
Nippon India Multi Cap Fund - Direct Plan - Growth Nippon India Multi Cap Fund - Direct Plan - Growth
Very High Risk
  • NAV ₹278.52
  • Fund Size ₹37,593.67Cr
Fund Return 27.05%
Category Return 23.39%
Nippon India Large Cap Fund - Direct Plan - Growth Plan Nippon India Large Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹88.07
  • Fund Size ₹35,667.30Cr
Fund Return 23.58%
Category Return 18.64%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
Kinjal Desai
May 25, 2018- Present
  • Schemes managed 52
  • Total AUM ₹ 3,78,885.93 Cr
  • Highest Return In 1 Yr 340.03 %
Other Funds
  • table
  • card
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹158.95
-4.89%
-5.81%
Very High Risk
₹57,009.70Cr
₹37.16
0.64%
1.53%
High Risk
₹979.71Cr
--
₹515.24
-2.24%
-4.14%
Very High Risk
₹8,160.74Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹158.95
-21.28%
-21.17%
Very High Risk
₹57,009.70Cr
₹37.16
2.03%
2.69%
High Risk
₹979.71Cr
--
₹515.24
-8.63%
-9.83%
Very High Risk
₹8,160.74Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹158.95
-21.59%
-21.36%
Very High Risk
₹57,009.70Cr
₹37.16
4.33%
4.54%
High Risk
₹979.71Cr
--
₹515.24
-11.73%
-11.92%
Very High Risk
₹8,160.74Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹158.95
7.90%
7.85%
Very High Risk
₹57,009.70Cr
₹37.16
9.08%
8.85%
High Risk
₹979.71Cr
₹515.24
12.49%
15.33%
Very High Risk
₹8,160.74Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹158.95
21.49%
16.56%
Very High Risk
₹57,009.70Cr
₹37.16
7.72%
9.70%
High Risk
₹979.71Cr
--
₹515.24
18.45%
17.30%
Very High Risk
₹8,160.74Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹158.95
34.38%
28.77%
Very High Risk
₹57,009.70Cr
₹37.16
9.10%
7.64%
High Risk
₹979.71Cr
--
₹515.24
26.94%
25.22%
Very High Risk
₹8,160.74Cr
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return -4.89%
Category Return -5.81%
Nippon India Credit Risk Fund Direct Plan Growth Option Nippon India Credit Risk Fund Direct Plan Growth Option
High Risk
  • NAV ₹37.16
  • Fund Size ₹979.71Cr
Fund Return 0.64%
Category Return 1.53%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -2.24%
Category Return -4.14%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return -21.28%
Category Return -21.17%
Nippon India Credit Risk Fund Direct Plan Growth Option Nippon India Credit Risk Fund Direct Plan Growth Option
High Risk
  • NAV ₹37.16
  • Fund Size ₹979.71Cr
Fund Return 2.03%
Category Return 2.69%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -8.63%
Category Return -9.83%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return -21.59%
Category Return -21.36%
Nippon India Credit Risk Fund Direct Plan Growth Option Nippon India Credit Risk Fund Direct Plan Growth Option
High Risk
  • NAV ₹37.16
  • Fund Size ₹979.71Cr
Fund Return 4.33%
Category Return 4.54%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -11.73%
Category Return -11.92%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return 7.90%
Category Return 7.85%
Nippon India Credit Risk Fund Direct Plan Growth Option Nippon India Credit Risk Fund Direct Plan Growth Option
High Risk
  • NAV ₹37.16
  • Fund Size ₹979.71Cr
Fund Return 9.08%
Category Return 8.85%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 12.49%
Category Return 15.33%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return 21.49%
Category Return 16.56%
Nippon India Credit Risk Fund Direct Plan Growth Option Nippon India Credit Risk Fund Direct Plan Growth Option
High Risk
  • NAV ₹37.16
  • Fund Size ₹979.71Cr
Fund Return 7.72%
Category Return 9.70%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 18.45%
Category Return 17.30%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return 34.38%
Category Return 28.77%
Nippon India Credit Risk Fund Direct Plan Growth Option Nippon India Credit Risk Fund Direct Plan Growth Option
High Risk
  • NAV ₹37.16
  • Fund Size ₹979.71Cr
Fund Return 9.10%
Category Return 7.64%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 26.94%
Category Return 25.22%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)
Akshay Sharma
Dec 1, 2022- Present
  • Schemes managed 51
  • Total AUM ₹ 3,78,879.77 Cr
  • Highest Return In 1 Yr 340.03 %
Other Funds
  • table
  • card
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
-2.24%
-4.14%
Very High Risk
₹8,160.74Cr
₹158.95
-4.89%
-5.81%
Very High Risk
₹57,009.70Cr
₹182.42
-1.90%
-1.92%
High Risk
₹8,757.84Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
-8.63%
-9.83%
Very High Risk
₹8,160.74Cr
₹158.95
-21.28%
-21.17%
Very High Risk
₹57,009.70Cr
₹182.42
-6.28%
-7.68%
High Risk
₹8,757.84Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
-11.73%
-11.92%
Very High Risk
₹8,160.74Cr
₹158.95
-21.59%
-21.36%
Very High Risk
₹57,009.70Cr
₹182.42
-6.61%
-8.31%
High Risk
₹8,757.84Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
₹515.24
12.49%
15.33%
Very High Risk
₹8,160.74Cr
₹158.95
7.90%
7.85%
Very High Risk
₹57,009.70Cr
₹182.42
7.12%
4.35%
High Risk
₹8,757.84Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
18.45%
17.30%
Very High Risk
₹8,160.74Cr
₹158.95
21.49%
16.56%
Very High Risk
₹57,009.70Cr
₹182.42
12.45%
10.72%
High Risk
₹8,757.84Cr
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
26.94%
25.22%
Very High Risk
₹8,160.74Cr
₹158.95
34.38%
28.77%
Very High Risk
₹57,009.70Cr
₹182.42
14.42%
12.96%
High Risk
₹8,757.84Cr
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -2.24%
Category Return -4.14%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return -4.89%
Category Return -5.81%
Nippon India Balanced Advantage Fund Direct Growth Plan Nippon India Balanced Advantage Fund Direct Growth Plan
High Risk
  • NAV ₹182.42
  • Fund Size ₹8,757.84Cr
Fund Return -1.90%
Category Return -1.92%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -8.63%
Category Return -9.83%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return -21.28%
Category Return -21.17%
Nippon India Balanced Advantage Fund Direct Growth Plan Nippon India Balanced Advantage Fund Direct Growth Plan
High Risk
  • NAV ₹182.42
  • Fund Size ₹8,757.84Cr
Fund Return -6.28%
Category Return -7.68%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return -11.73%
Category Return -11.92%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return -21.59%
Category Return -21.36%
Nippon India Balanced Advantage Fund Direct Growth Plan Nippon India Balanced Advantage Fund Direct Growth Plan
High Risk
  • NAV ₹182.42
  • Fund Size ₹8,757.84Cr
Fund Return -6.61%
Category Return -8.31%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 12.49%
Category Return 15.33%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return 7.90%
Category Return 7.85%
Nippon India Balanced Advantage Fund Direct Growth Plan Nippon India Balanced Advantage Fund Direct Growth Plan
High Risk
  • NAV ₹182.42
  • Fund Size ₹8,757.84Cr
Fund Return 7.12%
Category Return 4.35%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 18.45%
Category Return 17.30%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return 21.49%
Category Return 16.56%
Nippon India Balanced Advantage Fund Direct Growth Plan Nippon India Balanced Advantage Fund Direct Growth Plan
High Risk
  • NAV ₹182.42
  • Fund Size ₹8,757.84Cr
Fund Return 12.45%
Category Return 10.72%
Nippon India Pharma Fund - Direct Plan - Growth Plan Nippon India Pharma Fund - Direct Plan - Growth Plan
Very High Risk --
  • NAV ₹515.24
  • Fund Size ₹8,160.74Cr
Fund Return 26.94%
Category Return 25.22%
Nippon India Small Cap Fund - Direct Plan - Growth Plan Nippon India Small Cap Fund - Direct Plan - Growth Plan
Very High Risk
  • NAV ₹158.95
  • Fund Size ₹57,009.70Cr
Fund Return 34.38%
Category Return 28.77%
Nippon India Balanced Advantage Fund Direct Growth Plan Nippon India Balanced Advantage Fund Direct Growth Plan
High Risk
  • NAV ₹182.42
  • Fund Size ₹8,757.84Cr
Fund Return 14.42%
Category Return 12.96%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

DETAILED PORTFOLIO

As on Feb 2025
EQUITY (98.89%)
DEBT (0.00%)
CASH (1.11%)
Allocation by Market Cap

PERFORMANCE MEASURES

Fund evaluation across critical parameters for better decision making. Study period is 3 years.
  • Consistency
    i
    It represents the consistency of a fund in beating its benchmark.
    --
  • Downside Risk
    i
    Measured by Maximum Drawdown which shows the maximum loss from a peak to a nadir over a specified time period
    --
  • Risk Adjusted Return
    i
    Risk adjusted return represents the return generated after factoring the risk taken to achieve it.
    --
  • Volatility
    i
    Volatility represents the standard deviation of fund returns that is, how much the fund returns have deviated from the average.
    --
  • Upside Capture Ratio
    i
    Fund performance relative to the index when the market is up. An upside capture ratio of >100 indicates better fund performance.
    --
  • Downside Capture Ratio
    i
    Fund performance relative to the index when the market is down. A downside capture ratio of <100 indicates better fund performance.
    --

HISTORICAL RISK MEASURES

Statistical measures to evaluate mutual fund risk. All ratios are calculated for a three-year time duration.
  • Alpha: Excess return of the fund over benchmark
    i
    Any Alpha above zero is considered good. However, for comparison, a fund with a higher Alpha is considered better. Alpha is normally used in conjunction with Beta. If the Beta is high, it implies that the fund manager took a high risk to generate Alpha.
    1.39
    This Fund
    VS
    0.31
    Category Avg
  • Beta: Risk of the fund in relation to benchmark
    i
    Beta >1 indicates that the fund is more volatile than its benchmark while Beta < 1 indicates that the fund is less volatile than its benchmark. The Beta of the benchmark is equal to 1.
    0.91
    This Fund
    VS
    0.96
    Category Avg
  • Sortino Ratio: Return per unit of bad risk
    i
    A variation of Sharpe ratio, Sortino considers only the downside risk. Unlike Sharpe ratio which considers both good risk and bad risk, Sortino factors only the bad risk. A high Sortino ratio indicates better return for each unit of downside risk.
    1.31
    This Fund
    VS
    1.18
    Category Avg
  • R-Squared: How well the fund tracks benchmark
    i
    R-Squared measures the correlation of fund returns and its benchmark returns. It varies between 0 and 1. The metric, Beta makes no sense if R-Squared is equal to zero. Thus, both Beta and R-Squared should be used in conjunction. A fund with a high R-Squared and low Beta is considered a less risky fund.
    95.30
    This Fund
    VS
    94.94
    Category Avg
  • Sharpe Ratio: Risk adjusted return of the fund
    i
    Sharpe Ratio is a measure of return per unit of risk. A higher Sharpe ratio indicates better risk adjusted return given by the fund.
    0.77
    This Fund
    VS
    0.70
    Category Avg
  • Standard Devation: Volatility of the fund
    i
    Standard deviation is a measure of dispersion of fund returns from its average return. A fund with a higher Standard deviation is more volatile than a fund with a low standard deviation.
    15.63
    This Fund
    VS
    16.58
    Category Avg
Benchmark used in calculation : BSE Healthcare PR

PEER ANALYSIS

  • table
  • card
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹515.24
-2.24%
-4.14%
Very High Risk
₹8,160.74 Cr
--
₹312.68
-2.86%
-4.14%
Very High Risk
₹3,521.93 Cr
--
₹312.68
-2.86%
-4.14%
Very High Risk
₹3,521.93 Cr
--
₹152.14
-2.95%
-4.14%
Very High Risk
₹8,160.74 Cr
Nippon India Pharma Fund - Direct Plan - Bonus Plan Nippon India Pharma Fund - Direct Plan - Bonus Plan
VERY HIGH RISK --
  • NAV ₹515.24
  • Fund Size ₹8,160.74 Cr
Fund Return -2.24%
Category Return -4.14%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl Aditya Birla Sun Life Pharma & Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl
VERY HIGH RISK --
  • NAV ₹21.17
  • Fund Size ₹815.09 Cr
Fund Return -2.71%
Category Return -4.14%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
VERY HIGH RISK --
  • NAV ₹21.17
  • Fund Size ₹815.09 Cr
Fund Return -2.71%
Category Return -4.14%
SBI Healthcare Opportunities Fund Direct Reinvestment Inc Dist cum Cap Wdrl SBI Healthcare Opportunities Fund Direct Reinvestment Inc Dist cum Cap Wdrl
VERY HIGH RISK --
  • NAV ₹312.68
  • Fund Size ₹3,521.93 Cr
Fund Return -2.86%
Category Return -4.14%
SBI Healthcare Opportunities Fund Direct Payout Inc Dist cum Cap Wdrl SBI Healthcare Opportunities Fund Direct Payout Inc Dist cum Cap Wdrl
VERY HIGH RISK --
  • NAV ₹312.68
  • Fund Size ₹3,521.93 Cr
Fund Return -2.86%
Category Return -4.14%
Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl Nippon India Pharma Fund Direct Plan Reinvestment Inc Dist cum Cap Wdrl
VERY HIGH RISK --
  • NAV ₹152.14
  • Fund Size ₹8,160.74 Cr
Fund Return -2.95%
Category Return -4.14%
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

Top funds from this amc

  • table
  • card
Fund Name Morningstar Rating NAV Fund Return Category Return Risk Fund Size (Cr)
--
₹0.19
297.89%
--
Very High Risk
₹6.16 Cr
--
₹15.35
2.62%
1.74%
Very High Risk
₹556.92 Cr
--
₹35.17
1.31%
1.74%
High Risk
₹2,439.26 Cr
--
₹21.40
0.89%
--
Very High Risk
₹271.31 Cr
--
₹12.16
0.73%
--
Moderate Risk
₹743.67 Cr
Nippon India Credit Risk Fund Segregated Portfolio 1 Direct Growth Nippon India Credit Risk Fund Segregated Portfolio 1 Direct Growth
HIGH RISK --
  • NAV ₹0.53
  • Fund Size ₹23.68 Cr
Fund Return 298.36%
Category Return --
Nippon India Strategic Debt Fund Segregated Portfolio 1 Direct Growth Nippon India Strategic Debt Fund Segregated Portfolio 1 Direct Growth
VERY HIGH RISK --
  • NAV ₹0.19
  • Fund Size ₹6.16 Cr
Fund Return 297.89%
Category Return --
Nippon India Silver ETF Fund of Fund (FOF) Direct Growth Nippon India Silver ETF Fund of Fund (FOF) Direct Growth
VERY HIGH RISK --
  • NAV ₹15.35
  • Fund Size ₹556.92 Cr
Fund Return 2.62%
Category Return 1.74%
Nippon India Gold Savings Fund - Direct Plan - Growth Nippon India Gold Savings Fund - Direct Plan - Growth
HIGH RISK --
  • NAV ₹35.17
  • Fund Size ₹2,439.26 Cr
Fund Return 1.31%
Category Return 1.74%
Nippon India Japan Equity Direct Growth Nippon India Japan Equity Direct Growth
VERY HIGH RISK --
  • NAV ₹21.40
  • Fund Size ₹271.31 Cr
Fund Return 0.89%
Category Return --
Nippon India Nifty G-Sec Jun 2036 Maturity Index Fund Direct Growth Nippon India Nifty G-Sec Jun 2036 Maturity Index Fund Direct Growth
MODERATE RISK --
  • NAV ₹12.16
  • Fund Size ₹743.67 Cr
Fund Return 0.73%
Category Return --
Returns <= 1 year are absolute and > 1 year are annualised (CAGR)

ABOUT THE AMC

Nippon Life India Asset Management Ltd
Nippon Life India Asset Management Ltd manages assets worth ₹ 5,63,014.99 crores. It’s current offering of mutual fund schemes includes 29 equity, 78 debt and 12 hybrid schemes.
Phone
022-6808 7000/18602660111
Email
customercare@nipponindiaim.in
AUM
₹ 5,63,014.99 Cr (
As on Jan 2025
)
Address
4th Floor, Tower A, Peninsula Business Park, ,Mumbai ,400 013

FAQ’S

What is the category of Nippon India Pharma Fund - Direct Plan - Bonus Plan ?
The category of Nippon India Pharma Fund - Direct Plan - Bonus Plan is Equity - Sector - Healthcare
What is the current NAV of Nippon India Pharma Fund - Direct Plan - Bonus Plan ?
The current NAV of Nippon India Pharma Fund - Direct Plan - Bonus Plan (as on Mar 13, 2025) is ₹ 515.24
How safe is Nippon India Pharma Fund - Direct Plan - Bonus Plan?
The risk level of Nippon India Pharma Fund - Direct Plan - Bonus Plan is Very High .
What are short term returns given by Nippon India Pharma Fund - Direct Plan - Bonus Plan?
The return given by Nippon India Pharma Fund - Direct Plan - Bonus Plan in 1 month is -2.24%, 3 months is -8.63%, 6 months is -11.73%, and 1 year is 12.49%.
What are the long term returns given by Nippon India Pharma Fund - Direct Plan - Bonus Plan?
The return given by Nippon India Pharma Fund - Direct Plan - Bonus Plan in 3 years is 18.45% and 5 years is 26.94%.
What is the expense ratio of Nippon India Pharma Fund - Direct Plan - Bonus Plan?
The expense ratio of Nippon India Pharma Fund - Direct Plan - Bonus Plan is 1.03 %
What is the AUM of Nippon India Pharma Fund - Direct Plan - Bonus Plan
The assets under Management (AUM) of Nippon India Pharma Fund - Direct Plan - Bonus Plan is Rs 8,160.74 crores.
What is the minimum investment in Nippon India Pharma Fund - Direct Plan - Bonus Plan?
The minimum Lumpsum investment in Nippon India Pharma Fund - Direct Plan - Bonus Plan is ₹5000 and the minimum SIP investment in Nippon India Pharma Fund - Direct Plan - Bonus Plan is ₹100
What is the asset allocation of Nippon India Pharma Fund - Direct Plan - Bonus Plan?
The Nippon India Pharma Fund - Direct Plan - Bonus Plan has an exposure of 98.89% in Equity, and 1.11% in Cash & Money Market Securities
Advertisement